Decline depth
-26.2%
From rolling 252-day high of $93.61, 29d ago.
Past the 20% Watch threshold.
WatchRecovering
LQDALiquidia Corporation
Healthcare · Drug Manufacturers - Specialty & Generic · mid-cap ($3.3B)
-26.2%
from rolling 252-day high of $93.61 set 2026-08-11 · 29d ago
Current
$69.12
Decline depth
-26.2%
Decline σ
5.6σ
TFC
2/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$LQDA landed on the list 2026-03-04, down 26.3% from its 52-week high that day — now down -26.2%.
It has clawed back 74.4 percentage points off that level. It bottomed 26.3% below that high along the way.
From the 52-week high as of 2026-03-04 to today. Split-adjusted. Observed, not a forecast.
Structural break signals
LQDA qualifies for the Watch on decline depth.
Time-frame continuity
2/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
5.6σ
Drop over the last 20 bars in units of daily volatility (3.99%/day).
Past the ≥4σ Watch threshold.
The structural read
What price action says about LQDA.
LQDA qualifies for the Watch on decline depth — down -26.2% from its rolling 252-day high.
Cross-confirmation: decline sigma also reads 5.6σ over 20 bars.
A confirmed bullish signal on one or more time frames earned the Recovering badge. The tier says how deep the damage is; Recovering says momentum may be turning. Not a buy signal.
Whether LQDA's turn is investable is ConvictionEdge's question, not ours.
Upstream TFC read: strong alignment, current phase daily. Last bar types — daily 2U (green), weekly 1 (green), monthly 1 (green).
Earnings on file: 2026-03-05. Earnings dates don't affect tiering.
Questions about LQDA
What people ask.
Why is LQDA on Broken Stocks?
LQDA qualifies for the Watch on decline depth. It is down -26.2% from its rolling 252-day high of $93.61, set on 2026-08-11 — 29d ago. It additionally carries a Recovering badge — see below.
What does the Recovering badge mean for LQDA?
Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — LQDA is still Watch because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.
Is LQDA a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. LQDA is down -26.2% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is LQDA a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is LQDA trading inside its 52-week range?
At $69.12, LQDA sits 100.0% of the way from its 52-week low ($11.85) to its 52-week high ($46.67). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How does LQDA compare to its sector?
There are 276 other Healthcare tickers on Broken Stocks: 135 Red, 81 Amber, 60 Watch, with 33 showing recovering structural signals. Median sector decline is -35.2% — LQDA's decline is shallower than the sector median.
Does LQDA's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-03-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.